Not finding it? Sign in to also search OpenAlex live.
-
Umbilical Cord Blood as an Alternative to Neonatal Blood for Complete Blood Count: A Comparison Study2024 The Journal of Pediatrics article Medicine Clinical Laboratory Practices and Quality Control Open access
Lisanne E. Heeger, Myrthe I.J. Koster, Camila Caram‐Deelder, Vincent Bekker, Johanna G. van der Bom, Enrico Lopriore
6citations -
POS0440 REDUCTION IN MONOCYTE COUNT PREDICTS SUSTAINED REMISSION IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH ANTI-TNF THERAPY2021 Annals of the Rheumatic Diseases conference-abstract Medicine Rheumatoid Arthritis Research and Therapies Open access
Raj Amarnani, Muhammed Mainuddin, Muhammad Ruhul Amin Shipa, Su‐Ann Yeoh, Michael R. Ehrenstein
0citations -
Correlations between bone marrow radiation dose and hematologic toxicity in locally advanced cervical cancer patients receiving chemoradiation with cisplatin: a systematic review2021 Radiotherapy and Oncology review Physics and Astronomy Advanced Radiotherapy Techniques Open access
Anouk Corbeau, Sander C. Kuipers, Stephanie M. de Boer, Nanda Horeweg, Mischa S. Hoogeman, Jérémy Godart, +1 more
76citations -
Mapping Current and Emerging Laboratory Techniques for Haemoglobinopathy Carrier Detection and Prevention: A Narrative Review from the HELIOS Action2026 International Journal of Molecular Sciences review Medicine Hemoglobinopathies and Related Disorders Open access
Norafiza Mohd Yasin, Sotiroula Chatzimatthaiou, Adela Perolla, A del Cañizo Alvarez, Miguel Brito, Ghada Y. El‐Kamah, +4 more
1citations -
Adding eltrombopag to immunosuppressive treatment with cyclosporine as front-line therapy for moderate aplastic anemia improves trilineage hematologic response: One-year analysis of the randomised, placebo-controlled, double-blind Phase III trial eltrombopag for moderate aplastic anemia (EMAA Trial)2025 Blood conference-abstract Biochemistry, Genetics and Molecular Biology Blood disorders and treatments Open access
Britta Hoechsmann, Philippe Schafhausen, Fabian Beier, Michael Heuser, Joerg Westermann, Beatrice Drexler, +10 more
0citations -
Ruxolitinib Versus Best Available Therapy in Patients with Essential Thrombocythemia: Pre-Specified Interim Analysis of the Randomized Phase 2b Ruxobeat Clinical Trial of the German Study Group for Myeloproliferative Neoplasms (GSG-MPN)
Steffen Koschmieder, Susanne Isfort, Florian Heinrich Heidel, Andreas Hochhaus, Heiko Becker, Philipp Jakob Jost, +19 more
3citations -
Firstline Treatment with Ruxolitinib Versus Best Available Therapy in Patients with Polycythemia Vera: Pre-Specified Interim Analysis of the Randomized Phase 2b Ruxobeat Clinical Trial of the German Study Group for Myeloproliferative Neoplasms (GSG-MPN)
Steffen Koschmieder, Susanne Isfort, Lino Lars Teichmann, Philippe Schafhausen, Florian Heinrich Heidel, Andreas Hochhaus, +18 more
4citations -
Clinicohematologic and molecular response of essential thrombocythemia patients treated with pegylated interferon-α: a multi-center study of the German Study Group-Myeloproliferative Neoplasms (GSG-MPN)
Frank Stegelmann, Lino Lars Teichmann, Florian Heinrich Heidel, Carl C. Crodel, Thomas Ernst, Sebastian Kreil, +11 more
8citations -
Induction of a Systemic Immune Response during Use of an Allogenic Leukemia-Derived Dendritic Cell Vaccine in MRD+ AML Patients Correlates with Clinical Response and MRD Conversion
Arjan A. van de Loosdrecht, Jacqueline J Cloos, Eva‐Maria Wagner‐Drouet, Uwe Platzbecker, Tobias A.W. Holderried, Catharina H. M. J. van Elssen, +6 more
1citations -
Trial in Progress: A Randomized-Controlled Phase 2 Study Evaluating Venetoclax Plus Azacitidine Versus Intensive Chemotherapy in Adult Patients with Newly Diagnosed, NPM1-Mutated AML - the SAL/AMLCG Vincent Trial
Leo Ruhnke, Christoph Schliemann, Lars R. Fransecky, Björn Steffen, Martin Kaufmann, Andreas Burchert, +26 more
2citations -
Remission and Survival after Single Versus Double Induction with 7+3 for Newly Diagnosed Acute Myeloid Leukemia: Results from the Planned Interim Analysis of Randomized Controlled SAL-Daunodouble Trial
Christoph Röllig, Björn Steffen, Nael Alakel, Regina Herbst, Richard Noppeney, Maher Hanoun, +32 more
5citations -
The 2-year efficacy and safety of iptacopan monotherapy in patients with paroxysmal nocturnal hemoglobinuria with a history of aplastic anemia on concomitant immunosuppressive therapy who entered the roll-over extension program2025 Blood conference-abstract Immunology and Microbiology Complement system in diseases Open access
Régis Peffault de Latour, Anna Gayà, Morag Griffin, Bing Han, Austin Gladston Kulasekararaj, Jaroslaw Pawel Maciejewski, +11 more
0citations